Literature DB >> 30308184

Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator.

Zohreh Jahanafrooz1, Nasrin Motamed2, Beate Rinner3, Ahad Mokhtarzadeh4, Behzad Baradaran5.   

Abstract

Silibinin is a natural plant polyphenol with high antioxidant and anticancer properties, which causes broad-spectrum efficacy against cancer, including cell cycle arrest and apoptosis in most cancer cell types. Silibinin, by modulating the apoptosis, cell cycle progression and autophagic pathways in various cellular and molecular routs might be used to design more effective anticancer strategies. Silibinin also regulates aberrant miRNAs expression linked to many aspects of cell biology in cancer. Maybe the most interesting aspect of silibinin is its ability to trigger multiple cellular signaling pathways to induce a particular biologic effect in various cell types. This review discusses investigations supporting the ability of silibinin to be as a natural modulator of involved cellular biological events in cancer progression. In this review, we introduce the salient features of silibinin therapy to optimize clinical outcomes for oncology patients. The goal of the treatments is to make it possible to eliminate the tumor with the minimum side effects and cure the patient in the early stage cancer. Therefore, plant extracts such as silibinin can be included in the treatments.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Autophagy; Cancer; Cell cycle; Silibinin; microRNA

Mesh:

Substances:

Year:  2018        PMID: 30308184     DOI: 10.1016/j.lfs.2018.10.009

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  18 in total

Review 1.  Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer.

Authors:  Wenhao Luo; Lianfang Zheng; Taiping Tai Zhang
Journal:  Med Oncol       Date:  2021-05-21       Impact factor: 3.064

Review 2.  Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2020-05-28       Impact factor: 15.470

Review 3.  Involvement of Phytochemical-Encapsulated Nanoparticles' Interaction with Cellular Signalling in the Amelioration of Benign and Malignant Brain Tumours.

Authors:  Sidharth Mehan; Navneet Arora; Sonalika Bhalla; Andleeb Khan; Muneeb U Rehman; Badrah S Alghamdi; Torki Al Zughaibi; Ghulam Md Ashraf
Journal:  Molecules       Date:  2022-06-01       Impact factor: 4.927

4.  Silymarin inhibits the progression of Ehrlich solid tumor via targeting molecular pathways of cell death, proliferation, angiogenesis, and metastasis in female mice.

Authors:  Maggie E Amer; Maher A Amer; Azza I Othman; Doaa A Elsayed; Mohamed Amr El-Missiry; Omar A Ammar
Journal:  Mol Biol Rep       Date:  2022-03-19       Impact factor: 2.742

Review 5.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

6.  Inhibitory effect of hydnocarpin D on T-cell acute lymphoblastic leukemia via induction of autophagy-dependent ferroptosis.

Authors:  Siyue Lou; Huanwu Hong; Liwaliding Maihesuti; Hang Gao; Zhihui Zhu; Lili Xu; Shasha Tian; Guoyin Kai; Guozheng Huang; Huajun Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-29

Review 7.  Crosstalks between inflammasome and autophagy in cancer.

Authors:  Chaeuk Chung; Wonhyoung Seo; Prashanta Silwal; Eun-Kyeong Jo
Journal:  J Hematol Oncol       Date:  2020-07-23       Impact factor: 17.388

Review 8.  Metabolism, Transport and Drug-Drug Interactions of Silymarin.

Authors:  Ying Xie; Dingqi Zhang; Jin Zhang; Jialu Yuan
Journal:  Molecules       Date:  2019-10-14       Impact factor: 4.411

9.  MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy.

Authors:  Yalda Baghay Esfandyari; Mohammad Amin Doustvandi; Mohammad Amini; Behzad Baradaran; Sheyda Jodeiry Zaer; Nazila Mozammel; Mehdi Mohammadzadeh; Ahad Mokhtarzadeh
Journal:  Reprod Sci       Date:  2021-02-10       Impact factor: 3.060

10.  Targeting the hallmarks of cancer: the effects of silibinin on proliferation, cell death, angiogenesis, and migration in colorectal cancer.

Authors:  Saba Sameri; Chiman Mohammadi; Mehrnaz Mehrabani; Rezvan Najafi
Journal:  BMC Complement Med Ther       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.